Otakaro Pathways

11/09/2025

This poster was presented in by Dr Andrew Tie at the in Vienna, September 2025. We Discuss a potential relationship between Mycobacterium species and disease

21/06/2024

https://link.springer.com/article/10.1007/s10620-024-08503-9
The accompanying editorial on our paper from Digestive Diseases and Sciences.

Home Digestive Diseases and Sciences Article Putting Crohn’s Disease on the MAP: Potential Contribution of a “Stealth Pathogen” Invited Commentary Published: 20 June 2024 (2024) Cite this article Download PDF Digestive Diseases and Sciences Aims and scope Submit manuscript Putting Crohn’s Di...

21/06/2024

https://link.springer.com/article/10.1007/s10620-024-08508-4
Our latest paper published in the most recent issue of Digestive Diseases and Sciences.

Mycobacterium avium ssp. paratuberculosis (MAP) has been implicated in the development of Crohn’s disease (CD) for over a century. Similarities have been noted between the (histo)pathological presentation of MAP in ruminants, termed Johne’s disease (JD), and appearances in humans with CD. Analys...

02/05/2024

Otakaro Pathways contributed to this study by providing laboratory testing for cell wall deficient mycobacteria and we are collaborating on research with these isolates

24/04/2024

Otakaro Pathways has gone through a period of extensive experimental research and developmental research on our MAP blood test and we are now moving into applied science with the technology.

Otakaro Pathways - Seeking Better Ways To Stop Disease

16/04/2024

Otakaro Pathway's Mycobacteria blood test provides a new way to detect the presence of cell wall deficient "stealth pathogens" that are linked to Crohn's Disease as well as other chronic illness

Otakaro Pathways - Seeking Better Ways To Stop Disease

14/04/2024

Otakaro pathway's research into the relationship between Mycobacteria and Crohn's Disease has allowed us to develop our Mycobacteria blood test and assist with the diagnosis and treatment of chronic illness.

In ruminants Mycobacterium avium subspecies paratuberculosis (MAP) is the causative organism of a chronic granulomatous inflammatory bowel disease cal…

11/04/2024

Otakaro Pathways Mycobacteria blood test methods have opened the way for us to develop a new understanding of Crohn's Disease, as well as other chronic autoimmune illnesses. Creating opportunities for new treatments.

21/03/2024

Otakaro's latest paper detailing our recent research into organisms associated with Crohn's Disease.

Mycobacterium avium ssp. paratuberculosis (MAP) is the cause of Johne’s disease (JD), which is a chronic infectious gastrointestinal disease of ruminants and is often fatal. In humans, MAP has been associated with Crohn’s disease (CD) for over a century, without conclusive evidence of pathogenic...

10/08/2022

Otakaro Pathways has research interests in chronic diseases. This is a recent report of a fundamental problem with Alzheimer's research.

A neuroscience sleuth challenges data showing one toxic form of amyloid protein is a cause of brain condition

18/07/2022

Otakaro Pathways Ltd is a biodiscovery company which has developed methods to grow cell-wall-deficient mycobacteria (CWDM) These organisms are associated with Crohn’s disease and several other autoimmune and neuro-degenerative diseases.

The ability to cultivate CWDM in the laboratory has opened the door to understanding their suspected roles in some chronic human diseases.

Otakaro Pathways Ltd also carries out bioprospecting for novel compounds produced by indigenous organisms inhabiting Aotearoa. These organisms are of interest as sources of new antibiotics, remediation of the gut microbiome, and control of plant diseases.

We work with other researchers worldwide to gain a better understanding of disease through the principles of One Health.